ALS Worldwide welcomes any questions or comments you might have.  We provide free, personalized and confidential support services to anyone in the ALS community—whether you are a patient or a loved one, friend, health care professional or caregiver of someone diagnosed.

Get help now! Fill out the Online Profile Form or if you would prefer to talk with someone by email or phone first, please contact us at [email protected] or 1-608-663-0920.

For all other inquiries, please use the email form to the right and we will respond promptly to your request.Thank you.

ALS Worldwide
5808 Dawley Drive
Fitchburg, WI 53711‑7209

ALS Worldwide
Sorted by: January 2015 | View All
January 30, 2015

Neuralstem Clinical Trials

Dr. Eva Feldman, principal investigator of the ongoing Neuralstem Clinical Trials, and Neuralstem officers appear enthusiastic about Phase II clinical trial results.

January 29, 2015

A Review of Closed Clinical Trials

While there have been many clinical trials for ALS over the past 10 to 15 years, the results have frequesntly been unsuccessful.  A brief rationale is offered for your review. 

January 29, 2015


Tirasemtiv, developed by Cytokinetics, has shown some evidence of improvement in respiratory muscle function.  Robert Blum, CEO, met with Steve Byer to discuss future plans.

January 29, 2015

Restructuring Clinical Trial Design

Dexpramipexole, once thought to be the light at the end of a very dark tunnel, fell victim to the 'valley of death' Phase III clinical trial in 2013.

January 29, 2015

Why Most Clinical Trials Fail

Many scientists feel that today there exist better, more relevant testing models than SOD1 mice. There are far better models now available for testing new pharmaceuticals. 

January 28, 2015

How to Avoid Fraudulent Stem Cell Practitioners

ALS Worldwide seeks to empower patients and families by exposing deceitful organizations that make grandiose statements about their capabilities to treat or cure ALS/MND.